Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of ruxolitinib cream in prurigo nodularis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Prurigo Nodularis | Phase 3 | Status: COMPLETED | Results posted: 2025-11-24